Literature DB >> 26616356

Comparison of three transposons for the generation of highly productive recombinant CHO cell pools and cell lines.

Sowmya Balasubramanian1, Yashas Rajendra1, Lucia Baldi1, David L Hacker1,2, Florian M Wurm3.   

Abstract

Several naturally occurring vertebrate transposable elements have been genetically modified to enable the transposition of recombinant genes in mammalian cells. We compared three transposons-piggyBac, Tol2, and Sleeping Beauty-for their ability to generate cell pools (polyclonal cultures of recombinant cells) and clonal cell lines for the large-scale production of recombinant proteins using Chinese hamster ovary cells (CHO-DG44) as the host. Transfection with each of the dual-vector transposon systems resulted in cell pools with volumetric yields of tumor necrosis factor receptor-Fc fusion protein (TNFR:Fc) that were about ninefold higher than those from cell pools generated by conventional plasmid transfection. On average, the cell pools had 10-12 integrated copies of the transgene per cell. In the absence of selection, the volumetric productivity of the cell pools decreased by 50% over a 2-month cultivation period and then remained constant. The average volumetric TNFR:Fc productivity of clonal cell lines recovered from cell pools was about 25 times higher than that of cell lines generated by conventional transfection. In 14-day fed-batch cultures, TNFR:Fc levels up to 900 mg/L were obtained from polyclonal cell pools and up to 1.5 g/L from clonal cell lines using any of the three transposons. Biotechnol. Bioeng. 2016;113: 1234-1243.
© 2015 Wiley Periodicals, Inc. © 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  Sleeping Beauty; Tol2; cell pools; piggyBac; recombinant protein; transposon

Mesh:

Substances:

Year:  2015        PMID: 26616356     DOI: 10.1002/bit.25888

Source DB:  PubMed          Journal:  Biotechnol Bioeng        ISSN: 0006-3592            Impact factor:   4.530


  6 in total

1.  Single Copy Transgene Integration in a Transcriptionally Active Site for Recombinant Protein Synthesis.

Authors:  Sofie A O'Brien; Kyoungho Lee; Hsu-Yuan Fu; Zion Lee; Tung S Le; Christopher S Stach; Meghan G McCann; Alicia Q Zhang; Michael J Smanski; Nikunj V Somia; Wei-Shou Hu
Journal:  Biotechnol J       Date:  2018-07-30       Impact factor: 4.677

Review 2.  Progress of Transposon Vector System for Production of Recombinant Therapeutic Proteins in Mammalian Cells.

Authors:  Mian Wei; Chun-Liu Mi; Chang-Qin Jing; Tian-Yun Wang
Journal:  Front Bioeng Biotechnol       Date:  2022-05-04

Review 3.  Expression vector cassette engineering for recombinant therapeutic production in mammalian cell systems.

Authors:  Tian-Yun Wang; Xiao Guo
Journal:  Appl Microbiol Biotechnol       Date:  2020-05-06       Impact factor: 4.813

4.  Monoclonal antibodies expression improvement in CHO cells by PiggyBac transposition regarding vectors ratios and design.

Authors:  Samira Ahmadi; Fatemeh Davami; Noushin Davoudi; Fatemeh Nematpour; Maryam Ahmadi; Saeedeh Ebadat; Kayhan Azadmanesh; Farzaneh Barkhordari; Fereidoun Mahboudi
Journal:  PLoS One       Date:  2017-06-29       Impact factor: 3.240

Review 5.  Transposon vector-mediated stable gene transfer for the accelerated establishment of recombinant mammalian cell pools allowing for high-yield production of biologics.

Authors:  Natalie Tschorn; Karen Berg; Jörn Stitz
Journal:  Biotechnol Lett       Date:  2020-04-22       Impact factor: 2.461

Review 6.  Rat and Mouse Brain Tumor Models for Experimental Neuro-Oncology Research.

Authors:  Upasana Sahu; Rolf F Barth; Yoshihiro Otani; Ryan McCormack; Balveen Kaur
Journal:  J Neuropathol Exp Neurol       Date:  2022-04-27       Impact factor: 3.148

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.